Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease - Wikidata - awgldk - TriplyDB

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

http://www.wikidata.org/entity/Q42002890

about

The current research status of normal tension glaucoma Amyloidosis in Retinal Neurodegenerative Diseases Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model Ocular indicators of Alzheimer's: exploring disease in the retina Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review)The role of optical coherence tomography in Alzheimer's disease Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo.Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.Soluble and mature amyloid fibrils in drusen deposits Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina.Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.The ins and outs of cholesterol in the vertebrate retina.Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.Induction of amyloid-β(1-42) in the retina and optic nerve head of chronic ocular hypertensive monkeys Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease.Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus Amyloid β Peptide Induces Apoptosis Through P2X7 Cell Death Receptor in Retinal Cells: Modulation by Marine Omega-3 Fatty Acid DHA and EPA Cyclic intensive light exposure induces retinal lesions similar to age-related macular degeneration in APPswe/PS1 bigenic mice Ocular manifestations of Alzheimer's disease in animal models.Differential accumulation of secreted AbetaPP metabolites in ocular fluids Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease.Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease TRPC6: an underlying target for human glaucoma Retinal microvascular network attenuation in Alzheimer's disease Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin Biocompatibility of a Synthetic Biopolymer for the Treatment of Rhegmatogenous Retinal Detachment.Melanopsin retinal ganglion cell loss in Alzheimer disease.Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.Ocular changes in TgF344-AD rat model of Alzheimer's disease.Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration.Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.The retina as a window to the brain-from eye research to CNS disorders.Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?

P2860

Q22305862-A7B9D402-49D8-498A-B2EF-16434A4D5FAA Q26739839-BE664DFA-0217-4A0C-8AD4-8F93001AE5DD Q26752621-9ACA7822-1011-4F63-9463-3643E179744C Q27316689-A8519EEF-92A5-4792-A33B-E1E69B3694D9 Q28078670-B885FD19-1E6B-4C42-9106-B64A2BF6F6AA Q28079228-86A1DBAC-7B54-4C2B-914B-806BD56A2A9F Q28079500-A5984500-E607-4E6C-AA86-F3A64A9FDAA0 Q30498073-E04C1FE5-2F6A-42D0-A9D5-417ED1A2AACA Q33722131-1EB2E574-E83C-4D02-9AA1-4146A51D5E18 Q33735695-226F2CD7-3FB4-4C63-950E-58E1260379E7 Q34141680-A87D2413-696C-4D9B-9D6B-7E67E817FAAD Q34245979-FC1EC79E-B454-4EB2-8FDE-59F64C207287 Q34287793-CB8652EE-9A79-4A44-95A9-62C0856358C9 Q34349078-82C1DE88-EB0E-4DF9-8155-A2B83015F32F Q34483981-7BE51725-FAAF-4B4A-ABC2-996D3DA59796 Q34541965-661BE198-2248-4588-9A1E-3E55F64E11DA Q35497863-17160742-ECCF-4071-92D0-8A4135648CAE Q35705361-F35DED20-2517-4C20-AC2E-3BFB558FCCEC Q35740076-A80CAD25-4B49-4186-94D9-96142514F1B6 Q35743990-8D3FF574-AB06-4047-B756-D4CD6344707E Q35807628-F28EF46F-AE77-4953-85BB-6F5ED0ABE5FE Q35917824-C41A91BC-7004-4D5D-BA7E-B0E6A9B3D94D Q35993835-E9AD9494-5E57-4863-BD6B-2B99422F7BFF Q36097397-04A04C7C-BBA6-416A-BE09-A6EF5F961D84 Q36123754-163A1D39-79F4-4A1D-8281-458C7BDB6104 Q36163917-C7E48D33-131F-45F5-819F-6AF3F96CBD87 Q36192203-7EA77B42-2E4F-4AE6-AAFE-9FB524CD06EF Q36237609-90E5C72F-ECA1-4F72-8A7A-641D4CD88A59 Q36319298-C8C311B2-27BF-451D-81B8-3A8FF6649433 Q36429703-52DED0C0-8D3F-4010-8CE8-FE8E905AA4D8 Q36533171-6B79D3C3-454B-4786-9C4A-2D3723C1634F Q36566738-4319E151-4985-4F6C-985C-796547213057 Q37293239-7C50C130-41B5-48BE-869C-EB787156574B Q37503374-73CEB3B7-293D-46B8-A0F3-C15FFD768274 Q37533199-72C4CF5E-8280-4115-9F76-6B83638B1F12 Q37626384-89FEB901-2ADA-40EB-A05E-07FE2FBCD6BF Q37874157-AA505F8B-7895-4ED5-838A-1C0F10047A59 Q37985523-9D2B187E-D904-46B5-9FF2-456C2E575091 Q38061012-9D76C452-2A2E-451E-A95A-8042A6557BFE Q38061419-223A60D8-D7EA-4E48-8808-F766049D88DC

P2860

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

http://www.wikidata.org/entity/Q42002890

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@en

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@nl

type

label

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@en

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@nl

prefLabel

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@en

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@nl

P1433

Q42002890-013A9715-C195-4E2A-9595-6C67C11F3593

P1476

Q42002890-55691EB7-7172-4AEC-A50A-D0E2E66426E7

P2093

Q42002890-1D3D8DF0-390D-4284-873F-1304B8F0002F

Q42002890-811B3B79-AB10-4666-90CD-236A0955DBFF

Q42002890-99337113-75EF-4864-8698-6522C410BB80

Q42002890-9BDE6676-91E4-410B-9E45-BC2798C54805

Q42002890-AF4E4E02-45FB-49BC-A5C0-90F20E425881

P2860

Q42002890-0969CB72-F83D-4A0B-B4D4-77ABA69722C5

Q42002890-0C45CE82-C40F-43D0-8E58-396130080E22

Q42002890-14255FBD-B07F-4BE5-8A28-7FAFF4B6405D

Q42002890-15C0FBE8-62E6-4DD3-9E53-CA05C080B9A7

Q42002890-18BF8409-A776-4F9D-8B23-6FAF7FE70647

Q42002890-1C4D3972-E87C-4193-A27C-D5BDDCF6C840

Q42002890-279A6B09-D562-426F-935C-B8D8536FE426

Q42002890-284E8971-C169-4832-A24A-9BBBAB6195F1

Q42002890-2A9F514D-192B-4A67-91C0-EC4B5C131F02

Q42002890-2EF576EB-4EFA-4B02-8613-9A9F308E3D92

P304

Q42002890-5603FEA0-D3C9-4708-9E72-52CF36BBE721

P31

Q42002890-CFFB2A40-BD7A-4F86-9082-E5C853614D5B

P356

Q42002890-42A7C540-1470-496D-BB9D-DB50E8539C99

P407

Q42002890-C245E00B-3D46-4490-B40D-5E6D49AE07F7

P433

Q42002890-E077CB6A-4F3F-4855-8CCF-3964A9729AED

P478

Q42002890-0D66F563-5408-4AE0-B34A-2F268302D12A

P577

Q42002890-32898366-C812-4120-8743-45A126C2DB7D

P698

Q42002890-C9998045-F83D-41FC-A05F-FD4777EE23F3

P921

Q42002890-95D237FC-24CD-45E4-AF1F-96F363AA442B

P932

Q42002890-46F2E2E6-DC70-4401-8ACE-1E21A436F14E

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease

@en

P2093

Allison Ning

http://www.w3.org/2001/XMLSchema#string

Eleanor To

http://www.w3.org/2001/XMLSchema#string

Jing Cui

http://www.w3.org/2001/XMLSchema#string

Joanne Matsubara

http://www.w3.org/2001/XMLSchema#string

Karen Hsiao Ashe

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

Complement factor H polymorphism in age-related macular degeneration

Targeting amyloid-beta in glaucoma treatment.

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

Complement factor H variant increases the risk of age-related macular degeneration

Complement factor H polymorphism and age-related macular degeneration

P304

5136-5143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.08-1849

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18566467

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3947384

http://www.w3.org/2001/XMLSchema#string